Table 6. Sensitivity, Specificity, Positive Predictive Value, and Negative Predictive Value for Each Index Following PPSV in Adults Aged ≥19 Years, and PPSV and PCV in Children aged 0–18 Years, 2005–2016.
| Vaccine | Index | Known AEs | Sensitivity (%) | Specificity (%) | Positive predictive value (%) | Negative predictive value (%) | ||
|---|---|---|---|---|---|---|---|---|
| Yes | No | |||||||
| PRR, ROR | PPSV in adults | Yes | 10 | 4 | 40.0 | 66.7 | 71.4 | 34.8 |
| No | 15 | 8 | ||||||
| IC | Yes | 9 | 5 | 36.0 | 58.3 | 64.3 | 30.4 | |
| No | 16 | 7 | ||||||
| PRR, ROR | PPSV in children | Yes | 0 | 1 | 0.0 | 91.7 | 0.0 | 64.7 |
| No | 6 | 11 | ||||||
| IC | Yes | 2 | 0 | 33.3 | 100.0 | 100.0 | 73.3 | |
| No | 4 | 11 | ||||||
| PRR, ROR | PCV in children | Yes | 0 | 0 | 0.0 | 100.0 | N/A | 25.0 |
| No | 3 | 1 | ||||||
| IC | Yes | 0 | 1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| No | 3 | 0 | ||||||
PPSV, pneumococcal polysaccharide vaccine; PCV, pneumococcal conjugate vaccine; AE, adverse event; PRR, proportional reporting ratio; ROR, reporting odds ratio; IC 95% LCI, information component lower limit of 95% confidence interval; N/A, not applicable.